Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2009) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Critical Reviews in Toxicology | journal | 2.075 Q1 | 129 | 38 | 105 | 5576 | 694 | 99 | 4.47 | 146.74 |  |
| 2 | Natural Product Reports | journal | 2.925 Q1 | 211 | 77 | 186 | 11182 | 1455 | 181 | 7.70 | 145.22 | |
| 3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.728 Q1 | 99 | 25 | 69 | 3489 | 351 | 64 | 4.20 | 139.56 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | |
| 5 | Expert Opinion on Drug Discovery | journal | 0.463 Q3 | 84 | 92 | 303 | 9533 | 415 | 296 | 1.43 | 103.62 | |
| 6 | Expert Opinion on Therapeutic Targets | journal | 1.469 Q1 | 106 | 116 | 345 | 11796 | 1225 | 321 | 3.82 | 101.69 | |
| 7 | Expert Opinion on Drug Delivery | journal | 1.136 Q1 | 133 | 100 | 218 | 9913 | 758 | 204 | 3.20 | 99.13 | |
| 8 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | |
| 9 | Issues in Toxicology | book series | 0.197 Q3 | 18 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
| 10 | Expert Opinion on Therapeutic Patents | journal | 0.477 Q3 | 88 | 109 | 332 | 9508 | 405 | 321 | 1.21 | 87.23 | |
| 11 | Expert Review of Clinical Pharmacology | journal | 0.151 Q3 | 60 | 58 | 71 | 5034 | 32 | 61 | 0.45 | 86.79 | |
| 12 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | |
| 13 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 14 | Biomarkers in Medicine | journal | 0.187 Q4 | 56 | 70 | 50 | 5373 | 29 | 41 | 0.58 | 76.76 | |
| 15 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | |
| 16 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | |
| 17 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | |
| 18 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | |
| 19 | Future Medicinal Chemistry | journal | 90 | 120 | 0 | 8645 | 0 | 0 | 0.00 | 72.04 | | |
| 20 | Clinical Pharmacokinetics | journal | 1.494 Q1 | 184 | 60 | 212 | 4237 | 1153 | 202 | 5.36 | 70.62 | |
| 21 | Molecular Diagnosis and Therapy | journal | 0.754 Q2 | 68 | 34 | 123 | 2398 | 314 | 117 | 2.54 | 70.53 | |
| 22 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | |
| 23 | Current Opinion in Drug Discovery and Development | journal | 1.722 Q1 | 85 | 73 | 215 | 5063 | 1028 | 197 | 5.07 | 69.36 | |
| 24 | Trends in Pharmacological Sciences | journal | 5.016 Q1 | 244 | 81 | 283 | 5573 | 2791 | 267 | 9.25 | 68.80 | |
| 25 | Therapeutic Advances in Neurological Disorders | journal | 0.110 Q4 | 68 | 33 | 18 | 2252 | 9 | 13 | 0.50 | 68.24 | |
| 26 | Neuropsychopharmacology | journal | 3.590 Q1 | 249 | 255 | 835 | 16245 | 5588 | 800 | 6.85 | 63.71 | |
| 27 | HIV Therapy | journal | 14 | 60 | 0 | 3725 | 0 | 0 | 0.00 | 62.08 | | |
| 28 | Neuropharmacology | journal | 1.807 Q1 | 191 | 250 | 800 | 15008 | 3134 | 797 | 4.08 | 60.03 | |
| 29 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | |
| 30 | Toxin Reviews | journal | 0.158 Q4 | 54 | 32 | 64 | 1815 | 35 | 60 | 0.51 | 56.72 | |
| 31 | Autonomic and Autacoid Pharmacology | journal | 0.319 Q3 | 24 | 17 | 103 | 935 | 87 | 102 | 1.03 | 55.00 | |
| 32 | Particle and Fibre Toxicology | journal | 2.160 Q1 | 119 | 31 | 49 | 1670 | 331 | 46 | 5.18 | 53.87 | |
| 33 | Drug Discovery Today | journal | 1.979 Q1 | 215 | 154 | 459 | 8116 | 2858 | 433 | 6.23 | 52.70 | |
| 34 | Antiviral Chemistry and Chemotherapy | journal | 0.530 Q2 | 59 | 17 | 79 | 891 | 154 | 77 | 2.12 | 52.41 | |
| 35 | Tetrahedron | journal | 1.545 Q1 | 236 | 1290 | 3973 | 66897 | 13229 | 3940 | 3.45 | 51.86 | |
| 36 | Bioanalysis | journal | 70 | 128 | 0 | 6525 | 0 | 0 | 0.00 | 50.98 | | |
| 37 | Drug Safety | journal | 1.384 Q1 | 140 | 99 | 305 | 5046 | 1257 | 257 | 3.88 | 50.97 | |
| 38 | Pharmacogenomics | journal | 1.051 Q2 | 100 | 184 | 468 | 8961 | 1614 | 412 | 3.35 | 48.70 | |
| 39 | Toxicological Sciences | journal | 2.018 Q1 | 207 | 331 | 910 | 16093 | 4910 | 862 | 4.97 | 48.62 | |
| 40 | Drug Discovery Today: Disease Mechanisms | journal | 0.400 Q3 | 28 | 9 | 154 | 431 | 114 | 140 | 0.89 | 47.89 | |
| 41 | International Journal of Neuropsychopharmacology | journal | 1.897 Q1 | 125 | 136 | 294 | 6496 | 1149 | 263 | 4.07 | 47.76 | |
| 42 | Chinese Medicine | journal | 0.617 Q2 | 56 | 24 | 34 | 1143 | 91 | 32 | 2.40 | 47.63 | |
| 43 | Mutagenesis | journal | 1.169 Q1 | 102 | 62 | 173 | 2947 | 693 | 167 | 3.74 | 47.53 | |
| 44 | BMC Chemical Biology | journal | 0.634 Q2 | 21 | 7 | 8 | 330 | 15 | 8 | 1.80 | 47.14 | |
| 45 | Journal of Applied Toxicology | journal | 0.579 Q3 | 103 | 90 | 265 | 4146 | 606 | 260 | 2.32 | 46.07 | |
| 46 | Cardiovascular Therapeutics | journal | 0.927 Q2 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | |
| 47 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 4 | 0 | 180 | 0 | 0 | 0.00 | 45.00 | | |
| 48 | Environmental Pollution | journal | 2.002 Q1 | 301 | 440 | 1429 | 19704 | 5855 | 1410 | 3.71 | 44.78 | |
| 49 | Toxicon | journal | 0.756 Q2 | 144 | 246 | 733 | 10875 | 1782 | 720 | 2.35 | 44.21 | |
| 50 | Pharmacogenomics Journal | journal | 1.676 Q1 | 95 | 44 | 146 | 1939 | 760 | 145 | 4.92 | 44.07 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data